FERTIGO-MEDICAL Tsafrir Kolatt is the CEO of Fertigo Medical, a company devoted to increase the success rate in In-vitro Fertilization procedures. Prior to that Kolatt has led a few medical device and AI private and public companies (CEO, EVP, VP R&D) that developed new, successful devices for both therapy and diagnosis. Dr. Kolatt got his Ph.D. in theoretical astrophysics from the Hebrew University and was a post-doc researcher in Harvard University and UCSC. Kolatt published a few books, dozens of scientific papers and many popular articles. He won numerous scholarships and prizes for research, innovative product development, poetry and play-writing. He also serves as the chairperson of IYAR – the Israeli Institute for Advanced Research.
December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th & 12th, 2024
DIGITAL MEETINGS
MedFIT is your unique opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to build partnerships for all public and private actors, to source innovative and competitive early-stage R&D projects, to speed the emergence of collaborative projects, to increase licensing opportunities, to obtain funding and to facilitate market access.
Learn more
Organised by
INSTITUTIONAL PARTNERS
Keep up to date with the latest news from MedFIT!
Monthly newsletter
"*" indicates required fields
Event venue
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
Legal terms
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of MedFIT. And some are passing themselves off as being MedFIT organisation members and asking you to pay. Please note that the MedFIT team will never sell you the MedFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.